TME Pharma welcomes Dr. Alexandra Glucksmann to its Supervisory Board

– GERMANY, Berlin –  TME Pharma N.V. (EPA: ALTME), a clinical-stage biotechnology company focused on developing novel therapies for the treatment of cancer by targeting the tumor microenvironment (TME), announced the appointment of Dr.